Envoy Medical Warrant
COCHW
35 hedge funds and large institutions have $6.6M invested in Envoy Medical Warrant in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$455K |
| 2 |
Goldman Sachs
New York
|
+$305K |
| 3 |
FTCM
Fir Tree Capital Management
New York
|
+$288K |
| 4 |
LA
Linden Advisors
New York
|
+$273K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$249K |
Top Sellers
COCHW Hedge Fund Activity: Q2 2021 in Review
35 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q2 2021, worth a combined $6.6M.
Buyers outnumbered sellers: 35 funds opened new COCHW positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $455K.
- 35 institutional investors held Envoy Medical Warrant (COCHW) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $6.6M of Envoy Medical Warrant stock for Q2 2021.
- 35 funds opened new Envoy Medical Warrant positions in Q2 2021 and 0 closed out, a net change of +35 holders.
- The largest Envoy Medical Warrant buyer in Q2 2021 was Nomura Holdings, an estimated $455K added.
Based on aggregated 13F filings for Q2 2021.